Business

SNDL Takes Over Parallel to Claim Top Cannabis Store Count

mm
Add MyCannabis.com to your preferred sources on Google

SNDL Inc (SNDL ). has turned years of bad loans into ownership of a U.S. cannabis operator, and the Alberta company is now billing itself as the largest cannabis retailer in the world by number of stores. SNDL said it had completed the takeover of assets belonging to Parallel, a distressed multistate operator, on July 27, 2026. The superlative is real but narrow: it rests on store count, not revenue, and on operations SNDL does not yet directly control.

The deal gives SNDL a foothold in three states where it had never operated. The acquired assets include 56 retail locations, three cultivation and manufacturing facilities and about 800 employees across Florida, Texas and Massachusetts, generating roughly US$150 million in annualized revenue. They run under three brands: Surterra Wellness, with 43 dispensaries and a 175,000-square-foot grow in Florida; Goodblend, with 10 retail and pickup sites in Texas; and New England Treatment Access, or NETA, with three dispensaries in Massachusetts. In Texas, Goodblend is one of only three licensed operators serving a medical market of more than 31 million residents.

From creditor to owner

SNDL did not so much buy Parallel as foreclose on it. Through its SunStream Bancorp joint venture, SNDL was already Parallel’s lender: an affiliate, Talladega LP, extended a US$150 million secured loan in May 2021, and senior creditors advanced more cash as the company faltered. After Parallel defaulted and a sale process produced no acceptable third-party buyer, the creditors took the assets directly through a strict foreclosure, a lender’s remedy that hands over collateral to satisfy debt. The restructuring erased roughly US$842 million of Parallel’s obligations and left SNDL with indirect majority economic exposure equal to 66.7% of the new holding company’s equity and 69.4% of its debt.

Parallel’s collapse was years in the making. Chewing-gum heir William “Beau” Wrigley took over Surterra Wellness in 2018, rebranded it Parallel and pushed an aggressive multistate expansion. That plan unraveled in 2021, when a deal to take the company public at a $1.9 billion valuation through a special-purpose acquisition company fell apart; Wrigley stepped down and was later sued by investors, while landlords filed claims over unpaid rent. The foreclosure also followed the shutdown of Parallel’s two Florida cultivation sites, which cost 211 jobs.

What “largest” actually means

SNDL’s claim is a counting exercise. The company says it now supports a 249-store retail network, its Canadian base plus the 56 U.S. locations, which chief executive Zach George called “the largest in the world by store count.” That edges past High Tide (HITI ), the Calgary retailer whose Canna Cabana chain reached 229 stores in July 2026. High Tide, which recently moved to shield its store licenses from a hostile takeover with a shareholder rights plan, still bills itself as Canada’s largest cannabis retailer. By revenue the picture flips: SNDL’s trailing sales sit near C$928 million, and several U.S. multistate operators book more.

Even SNDL’s own framing wavers. The completion announcement claimed the largest cannabis retail network in the world by store count; its second-quarter results, released July 28, 2026, described the more modest goal of becoming the largest in North America by store count, and tied even that to gaining direct control.

That control is the catch. SNDL does not yet consolidate Parallel’s operations: its stake sits indirectly inside SunStream and is carried under the equity method, so the closing barely moves SNDL’s books beyond the purchase of a US$29.75 million loan position at a 25% discount to face value. The company expects to convert the indirect exposure into direct, consolidated control in the coming months, subject to legal, regulatory, accounting and Nasdaq requirements, and it plans to keep Parallel’s Massachusetts adult-use business deconsolidated to protect its Nasdaq listing.

A lender’s playbook, and a soft quarter

The takeover fits a widening pattern in which distressed cannabis lenders end up as operators; SunStream earlier absorbed Michigan’s Skymint through a comparable restructuring. The timing also tracks a broader thaw at mainstream exchanges: U.S. authorities moved state-regulated medical cannabis to Schedule III in April 2026, and restructured operators including Trulieve have since pursued New York Stock Exchange listings, a path SNDL now hopes to follow onto Nasdaq.

SNDL has the balance sheet to press its advantage. The diversified cannabis-and-liquor retailer ended June 2026 debt-free, with C$183.2 million in cash and a wider C$598.5 million in cash, marketable securities and investments, and it has repurchased more than 29 million shares since late 2024. Its core business, however, is under strain: second-quarter revenue fell 3.7% to C$235.8 million, gross margin narrowed to 23.9% from 27.6% a year earlier, and the company posted a C$7.8 million operating loss. Whether the largest-by-store-count title becomes more than a marketing line now depends on SNDL taking control of, and making money from, a U.S. operator it does not yet run.

Marcus Lin is an AI-generated analyst at MyCannabis.com, covering cannabis companies, industry strategy, and market structure across regulated jurisdictions. His work focuses on how licensed producers, processors, and ancillary businesses operate within evolving regulatory environments—and how business decisions shape long-term market viability.
With a business-focused and analytical perspective, Marcus examines company strategy, consolidation trends, supply chain dynamics, and capital deployment across the cannabis sector. He places particular emphasis on execution, regulatory alignment, and the structural factors that determine whether companies can scale sustainably in legal markets.
Articles authored by Marcus Lin are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, context, and responsible coverage of cannabis industry developments in regulated markets.